Transdermal Delivery of Ondansetron Hydrochloride: Effects of Vehicles and Penetration Enhancers

Drug Development and Industrial Pharmacy

Volumn 30, Issue 2, 2004, Pages 187-194

  Gwak, Hye Sun ^a   Oh, Ik Sang ^b   Chun, In Koo ^b  

^a Chosun University   (South Korea)

^b Dongduk Women's University   (South Korea)

Author keywords

Ondansetron hydrochloride; Penetration enhancers; Transdermal delivery; Vehicles

Indexed keywords

CAPRYOL; CAPSAICIN; DECANOIC ACID; DIETHYLENE GLYCOL MONOETHYL ETHER; FATTY ACID; FATTY ALCOHOL; LAURIC ACID; LAUROGLYCOL; LINOLEIC ACID; OCTANOIC ACID; OLEIC ACID; OLEYL ALCOHOL; ONDANSETRON; PROPYLENE GLYCOL; PROPYLENE GLYCOL MONOCAPRYLATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; SKIN PENETRATION;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIEMETICS; FEASIBILITY STUDIES; MALE; MICE; MICE, INBRED HRS; ONDANSETRON; PERMEABILITY; SKIN ABSORPTION; VEHICLES;

EID: 1842589374     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120028714     Document Type: Article

References (26)

1. Ye, J.H.; Ponnudurai, R.; Schaefer, R. Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev. 2001, 7 (2), 199-213.
2. Walton, S.M. Advances in use of the 5-HT3 receptor antagonists. Expert Opin. Pharmacother. 2000, 1 (2), 207-223.
3. Gregory, R.E.; Ettinger, D.S. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting: a comparison of their pharmacology and clinical efficacy. Drugs 1998, 55 (2), 173-189.
4. Blackwell, C.P.; Harding, S.M. The clinical pharmacology of ondansetron. Eur. J. Cancer Clin. Oncol. 1989, 25 (Suppl. 1), S21-S24.
5. Gwak, H.S.; Chun, I.K. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm. 2002, 236 (1-2), 57-64.
6. Gwak, H.S.; Kim, S.U.; Chun, I.K. Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin. Arch. Pharm. Res. 2002, 25 (3), 392-396.
7. Nokhodchi, A.; Shokri, J.; Dashbolaghi, A.; Hassan-Zadeh, D.; Ghafourian, T.; Barzegar-Jalali, M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int. J. Pharm. 2003, 250 (2), 359-369.
8. Culy, C.R.; Bhana, N.; Plosker, G.L. Ondansetron: a review of its use as an antiemetic in children. Paediatr. Drugs 2001, 3 (6), 441-479.
9. Barry, B.W. Percutaneous absorption. In Dermatological Formulations; Barry, B.W., Ed.; Marcel Dekker, Inc.: New York, 1983; 49-94.
10. Friend, D.R.; Heller, J. Simple alkyl esters as skin penetration enhancers. In Pharmaceutical Skin Penetration Enhancement; Walters, K.A., Hadgraft, J., Eds.; Marcel Dekker, Inc.: New York, 1993; 31-56.
11. Kim, D.D.; Kim, J.L.; Chien, Y.W. Mutual hairless rat skin permeation-enhancing effect of ethanol/water system and oleic acid. J. Pharm. Sci. 1996, 85 (11), 1191-1195.
12. Doh, H.J.; Cho, W.J.; Yong, C.S.; Choi, H.G.; Kim, J.S.; Lee, C.H.; Kim, D.D. Synthesis and evaluation of ketorolac ester prodrugs for transdermal delivery. J. Pharm. Sci. 2003, 92 (5), 1008-1017.
13. Shirley, M.N. Compatibility and synergy of permeation enhancers with solvents, excipients, and drugs. In Drug Permeation Enhancement; Dean, S.H., Ed.; Marcel Dekker, Inc.: New York, 1994; 91-105.
14. Barry, B.W. Mode of action of penetration enhancers in human skin. J. Control. Release 1987, 6, 85-97.
15. Goto, S.; Uchida, T.; Lee, C.K.; Yasutake, T.; Zhang, J.B. Effect of various vehicles on ketoprofen permeation across excised hairless mouse skin. J. Pharm. Sci. 1993, 82 (9), 959-963.
16. Oh, H.J.; Oh, Y.K.; Kim, C.K. Effects of vehicles and enhancers on transdermal delivery of melatonin. Int. J. Pharm. 2001, 212 (1), 63-71.
17. Cho, Y.J.; Choi, H.K. Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm. 1998, 169 (1), 95-104.
18. Green, P.G.; Guy, R.H.; Hadgraft, J. In vitro and in vivo enhancement of skin permeation with oleic acid and lauric acids. Int. J. Pharm. 1988, 48 (1-3), 103-111.
19. Yamada, M.; Uda, Y.; Tanigawara, Y. Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem. Pharm. Bull. 1987, 35 (8), 3399-3406.
20. Cooper, E.R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 1984, 73 (8), 153-1156.
21. Cooper, E.R.; Merritt, E.W.; Smith, R.L. Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J. Pharm. Sci. 1985, 74 (6), 688-689.
22. Aungst, B.J.; Rogers, N.J.; Shefter, E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 1986, 33 (1-3), 225-234.
23. Elias, P.M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 1983, 80 (1), 44-49.
24. Nomura, H.; Fusao, K.; Sugimoto, Y.; Miyashita, Y.; Dohi, M.; Kato, Y. Percutaneous absorption of indomethacin from mixtures of fatty alcohol and propylene glycol (FAPG bases) through rat skin: effects of oleic acid added to FAPG base. Chem. Pharm. Bull. 1990, 38 (5), 1421-1424.
25. Kitagawa, S.; Endo, J.; Kametani, F. Effects of long-chain cis-unsaturated fatty acids and their alcohol analogues on aggregation of bovine platelets and their relation with membrane fluidity change. Biochem. Biophys. Acta 1985, 818 (2), 391-397.
26. Degim, I.T.; Uslu, A.; Hadgraft, J.; Atay, T.; Akay, C.; Cevheroglu, S. The effects of Azone and capsaicin on the permeation of naproxen through human skin. Int. J. Pharm. 1999, 179 (1), 21-25.